In addition to being an established risk factor for neurodegenerative diseases, age is increasingly recognized as adversely influencing regeneration. Accumulating evidence also suggests that age plays important, although poorly understood, roles with respect to course and prognosis in the degenerative and untreatable later phase of multiple sclerosis. Two experimental models of multiple sclerosis have been particularly influential in modeling the different aspects of neuronal injury and regeneration: global experimental autoimmune encephalomyelitis and focal toxin-mediated injury. Against this background, we report a focal model of immune-mediated demyelinating injury that reliably generates targeted primary demyelination and axonal injury....
Multiple Sclerosis (MS) is a heterogeneous disease that impacts the brain, spinal cord, and optic ne...
Remyelination is in the center of new therapies for the treatment of multiple sclerosis to resolve a...
The failure of remyelination in the human CNS contributes to axonal injury and disease progression i...
Remyelination is a neuroprotective regenerative response to demyelination that restores saltatory co...
SummaryRemyelination is a regenerative process in the central nervous system (CNS) that produces new...
International audienceIt is widely thought that brain repair does not occur, but myelin regeneration...
Aging has been shown to detrimentally affect oligodendrocyte function in axon remyelination. Examini...
The regenerative capacity of the peripheral nervous system declines with age. Why this occurs, howev...
SummaryThe regenerative capacity of the peripheral nervous system declines with age. Why this occurs...
Although aggravated multiple sclerosis (MS) disability has been reported in aged patients, the aging...
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) that leads to...
Multiple sclerosis (MS) is a CNS neurodegenerative autoimmune disease characterized by loss of oligo...
Current therapies for multiple sclerosis (MS) reduce the frequency of relapses by modulating adaptiv...
Loss of oligodendrocytes is a feature of many demyelinating diseases including multiple sclerosis. H...
Multiple sclerosis is a debilitating disease of the central nervous system that has been characteris...
Multiple Sclerosis (MS) is a heterogeneous disease that impacts the brain, spinal cord, and optic ne...
Remyelination is in the center of new therapies for the treatment of multiple sclerosis to resolve a...
The failure of remyelination in the human CNS contributes to axonal injury and disease progression i...
Remyelination is a neuroprotective regenerative response to demyelination that restores saltatory co...
SummaryRemyelination is a regenerative process in the central nervous system (CNS) that produces new...
International audienceIt is widely thought that brain repair does not occur, but myelin regeneration...
Aging has been shown to detrimentally affect oligodendrocyte function in axon remyelination. Examini...
The regenerative capacity of the peripheral nervous system declines with age. Why this occurs, howev...
SummaryThe regenerative capacity of the peripheral nervous system declines with age. Why this occurs...
Although aggravated multiple sclerosis (MS) disability has been reported in aged patients, the aging...
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) that leads to...
Multiple sclerosis (MS) is a CNS neurodegenerative autoimmune disease characterized by loss of oligo...
Current therapies for multiple sclerosis (MS) reduce the frequency of relapses by modulating adaptiv...
Loss of oligodendrocytes is a feature of many demyelinating diseases including multiple sclerosis. H...
Multiple sclerosis is a debilitating disease of the central nervous system that has been characteris...
Multiple Sclerosis (MS) is a heterogeneous disease that impacts the brain, spinal cord, and optic ne...
Remyelination is in the center of new therapies for the treatment of multiple sclerosis to resolve a...
The failure of remyelination in the human CNS contributes to axonal injury and disease progression i...